ADIPOQ and metabolic syndrome: This ratio could be an atherosclerotic risk maker (65) while the adiponectin/leptin ratio could be a valuable complementary element in prediction and prevention of cardiovascular diseases and metabolic syndrome (66, 67), suggesting that our therapy was effective to improve these parameters.